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Available online 9 July 2014Abstract Adult mammals undergo minimal regeneration following cardiac injury, which severely compromises cardiac
function and contributes to the ongoing burden of heart failure. In contrast, the mammalian heart retains a transient capacity
for cardiac regeneration during fetal and early neonatal life. Recent studies have established the importance of several
evolutionarily conserved mechanisms for heart regeneration in lower vertebrates and neonatal mammals including induction of
cardiomyocyte proliferation, epicardial cell activation, angiogenesis, extracellular matrix deposition and immune cell
infiltration. In this review, we provide an up-to-date account of the molecular and cellular basis for cardiac regeneration in
lower vertebrates and neonatal mammals. The historical context for these recent findings and their ramifications for the future
development of cardiac regenerative therapies are also discussed.
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Since the first systematic studies of organ regeneration in
the 18th century, countless biologists have interrogated the
mechanisms by which animals replace lost body parts.
Regenerative phenomena have since been described in
hydra, crustaceans, worms, fruit flies, frogs, salamanders,
zebrafish, rodents and humans. Organ regeneration involves
an astonishing diversity of cellular mechanisms including
recruitment and activation of stem cells, as well as
de-differentiation, trans-differentiation and proliferation
of differentiated cell types (Poss, 2010). Despite a rich
history of regeneration research spanning several hundreds
of years, the first descriptions of cardiac regeneration in
lower vertebrates were only reported within the last few
decades (Oberpriller and Oberpriller, 1974; Rumyantsev,
1966; Rumyantsev, 1961). The paucity of early studies on
heart regeneration, even in highly regenerative lower
vertebrates, is likely a consequence of the conceptual
constraints that were imposed by the long standing dogma
that the adult heart was terminally differentiated and
lacked any appreciable regenerative capacity, a view that
underpinned mammalian cardiac biology for over a century
(Goldemberg, 1886).
It is not unreasonable that the heart has been tradition-
ally viewed as a non-regenerative organ. In response to
cardiac injury, such as that induced by a myocardial
infarction, the adult mammalian heart fails to replace the
vast majority of cardiomyocytes that are lost or damaged. In
the absence of a robust regenerative response, the heart
substitutes the lost cardiomyocytes with scar tissue, which
contributes to the contractile demise of the organ and
ultimately leads to heart failure. However, the traditional
view of the heart as a terminally differentiated organ
without any capacity for cardiomyocyte renewal has been
emphatically refuted in recent years by a growing number of
studies in humans (Bergmann et al., 2009; Quaini et al.,
2002; Beltrami et al., 2001) and other mammals (Beltrami et
al., 2003; Hsieh et al., 2007; Senyo et al., 2013). The
underlying mechanisms for cardiomyocyte regeneration
remain highly controversial but the degree of cell turnover
is clearly insufficient to replace the large number of
cardiomyocytes (up to 1 billion in humans) that are lost
following a major ischemic event. As such, regeneration of
myocardial tissue following injury remains a major goal of
contemporary research in the field. A number of cardiac
regenerative strategies have been proposed including cell
replacement therapies, activation of endogenous progenitor
cell populations, cardiomyocyte cell cycle re-entry and,
most recently, direct lineage reprogramming. However,
while all of these approaches offer hope to heart failure
patients, they all currently suffer from inherent limitations
and translational barriers (Hudson and Porrello, 2013). An
alternative and complimentary approach is to explore, and
ultimately attempt to recapitulate, innate mechanisms of
cardiac regeneration such as those that have evolved in
highly regenerative organisms, such as the zebrafish, as wellas those that exist during privileged developmental windows
in mammals. In this review, we provide an overview of
cardiac regenerative phenomena in lower vertebrates and
neonatal mammals, with a particular emphasis on recent
advances that are beginning to shed light on the underlying
molecular and cellular mechanisms that govern cardiac
regenerative capacity during mammalian development.Cardiac regeneration in lower vertebrates
In the 1960s, scientists working in the former Soviet Union
conducted the first studies of cardiac regeneration in
amphibians (Rumyantsev, 1966; Rumyantsev, 1961; Sulima,
1968). Mitotic cells were observed following cardiac injury
in lower vertebrates, including adult frogs, newts and
axolotls (Rumyantsev, 1966; Rumyantsev, 1961; Sulima,
1968; Rumyantsev, 1973). Later transmission electron
microscopy studies following resection of the ventricular
apex of adult newts confirmed the presence of mitotic
cardiomyocytes in the wounded area but failed to document
complete regeneration of the myocardium, which was charac-
terized by the presence of connective scar tissue following
injury (Oberpriller and Oberpriller, 1974; Oberpriller and
Oberpriller, 1971). Collectively, these early studies suggested
that although amphibians are capable of inducing cardiomyo-
cyte proliferation following injury, the regenerative response is
incomplete. However, a more recent study by Witman and
colleagues has provided evidence for complete regeneration of
the adult newt heart following resection of a small region of
heart tissue at the base of the cardiac ventricles (Witman
et al., 2011). In contrast to earlier studies where the entire
ventricular apex was removed, Witman et al. induced a mode
of injury that does not breach the ventricular cavity (Fig. 1).
Resection of the base of the cardiac ventricles in adult newts
was associated with gradual restoration of the myocardial
tissue over a period of 60 days (Witman et al., 2011). Although
these results were at odds with earlier reports of a much more
limited regenerative potential of the adult newt heart, the
earlier studies may have been prematurely terminated for
histological analyses, prior to completion of the reverse
remodeling phase, which must take place in order for the
heart to regain its normal morphological appearance (Witman
et al., 2011). In addition, the anatomical location of the
injury site near the atrioventricular boundary could be
important and may reflect a differential regenerative capacity
of cardiomyocytes or progenitor cells located in this region
compared with the apex of the adult newt heart.
In contrast to the variable descriptions of heart regeneration
in amphibians, zebrafish can regenerate following multiple
types of cardiac injury including ventricular resection,
cryoinjury and genetic cardiomyocyte ablation (Gonzalez-Rosa
et al., 2011; Poss et al., 2002;Wang et al., 2011). Cardiac injury
induces amarked increase in cardiomyocyte proliferation in the
adult zebrafish heart and genetic lineage tracing experiments
suggest that the vast majority of regenerated cardiomyocytes
are derived from pre-existing cardiomyocytes rather than from
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Figure 1 Different injury models for studies of cardiac regeneration in the newt, zebrafish and neonatal mouse. Cardiomyocyte
proliferative responses (localized or global) and the outcomes of genetic lineage tracing experiments are highlighted. Green dots
denote proliferating cardiomyocytes.
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559A neonatal blueprint for cardiac regenerationa stem cell population (Jopling et al., 2010; Kikuchi et al.,
2010). Regenerative mechanisms in different adult zebrafish
cardiac injury models have been described in detail elsewhere
(Kikuchi and Poss, 2012) and are summarized in Fig. 1.
Cardiac regeneration in mammals— privileged
windows of development
Since Spallanzani's seminal treatise on the age-dependency
of tail regeneration in tadpoles and salamanders almost
250 years ago (Spallanzani, 1768), the relationship between
development and regeneration has received much attention.
While the adult human heart does not undergo any apprecia-
ble regeneration following injury, the possibility of cardiac
regeneration in children and infants has been considered for
almost a century. The earliest reports of cardiac regeneration
in children involved careful analyses of post-mortem histolog-
ical specimens from children with diphtheria (McMahon, 1937;
Warthin, 1924). The presence of mitotic figures and splitting
of myocardial fibers in such cases led to the suggestion that
cardiac regeneration might be possible during early develop-
mental stages (McMahon, 1937). There is even some evidence
for cardiac regeneration in children undergoing corrective
cardiac surgery for congenital heart malformations (Fratz
et al., 2011). However, direct experimental evidence for this
developmental phenomenon has only been provided very
recently in different mammalian model systems.
The heart undergoes rapid growth and remodeling during
embryogenesis. The heart also retains significant growth
plasticity during embryonic and fetal life in the face of
different environmental insults including nutrient deprivation,
variations in litter size, changes in blood flow, as well as
mechanical and volume loading (Porrello et al., 2008). Such
plasticity is presumably lost during postnatal life, as genetic
and environmental insults that lead to excessive myocyte loss
during early development are frequently associated with
maladaptive compensatory remodeling and cardiac pathologies
in adulthood (Delgado-Olguin et al., 2012; Levkau et al., 2008;
Porrello et al., 2009). The most compelling evidence for
cardiac regeneration during embryogenesis comes from genet-
ic studies in mice. Similar to genetic cardiomyocyte ablation
studies in zebrafish, Drenckhahn et al. have provided evidence
for compensatory growth of healthy cardiac cells in diseased
embryonic mouse hearts (Drenckhahn et al., 2008). In response
to heterozygous deletion of the X-linked Holocytochrome c
synthase (Hccs) gene, encoding an enzyme required for
mitochondrial respiration, heterozygous female embryos
were able to compensate for a 50% deficiency in cardiac
cells. Interestingly, the remaining healthy cells gradually
replaced the diseased cells over time, suggesting that the
embryonic heart has significant regenerative capacity. The
embryonic regenerative response in embryonic mice was
associated with robust induction of cardiomyocyte prolifera-
tion in healthy cells, which likely underlies the enhanced
regenerative capacity at early developmental stages prior to
the onset of postnatal mitotic arrest in mammals (Drenckhahn
et al., 2008). Interestingly, a significant proportion of
Hccs-deficient cells were still present in the ventricles of
neonatal mice (~30% in the interventricular septum), suggest-
ing that this innate cardiac regenerative capacity might extend
into the early postnatal period (Drenckhahn et al., 2008).In order to determine whether the neonatal mammalian
heart harbors any significant regenerative capacity, we
recently developed a surgical model of cardiac injury in
1-day-old neonatal mice (Fig. 1) (Porrello et al., 2011a).
Following amputation of a portion of the ventricular apex
comprising approximately 15% of the ventricle, neonatal
mice mounted a regenerative response that restored the lost
myocardial tissue over a period of 3 weeks. Apical resection
injury was associated with a series of cellular events highly
reminiscent of cardiac regeneration in lower vertebrates,
including formation of a blood clot, recruitment of inflam-
matory cells to the site of injury, epicardial cell activation,
early extracellular matrix deposition, cardiomyocyte prolif-
eration and restoration of normal cardiac function (Porrello
et al., 2011a). The ability to efficiently regenerate heart
muscle following amputation was lost by postnatal day 7,
coinciding with the developmental window when rodent
cardiomyocytes begin to lose their proliferative potential
(Li et al., 1996; Soonpaa and Field, 1997). Genetic lineage
tracing studies confirmed that the vast majority of re-
generated cardiomyocytes in 1-day-old mice were derived
from pre-existing cardiomyocytes through cell prolifera-
tion (Porrello et al., 2011a). However, a minor contribution of
non-myocytes to neonatal cardiac regeneration could not
be excluded due to limitations in the cardiomyocyte labeling
efficiency that could be achieved using the tamoxifen-
inducible Myh6-MerCreMer transgenic system (~70–80% in P1
mice) (Porrello et al., 2011a).
More recent studies by our group and others suggest that
1-day-old neonatal mice are also capable of undergoing
cardiac regeneration following myocardial infarction, which
is the leading cause of heart failure in humans (Haubner et
al., 2012; Porrello et al., 2013). Myocardial ischemia was
induced by permanent ligation of the left anterior descend-
ing coronary artery (LAD) in 1-day-old mice (Fig. 1). LAD
ligation was associated with a marked reduction in myocar-
dial viability and a dramatic decline in cardiac function at day
3 following infarction (Porrello et al., 2013). However, within
3 weeks, neonatal mice were able to launch a regenerative
response that restored 95% of the infarcted myocardium and
returned cardiac function to normal. Importantly, cardiac
function was still unperturbed at 9 months of age, suggesting
that the neonatal regenerative response can sustain cardiac
function for several months following injury (Porrello et al.,
2013). Similar to cryocauterization in the zebrafish, neonatal
infarction was associated with early collagen deposition,
which later regressed and became marginalized to the
periphery of the tissue. Little to no fibrosis was detectable
at 3 weeks following infarction, with the exception of a small
region of tissue immediately adjacent to the ligature (Porrello
et al., 2013). Histological and genetic lineage tracing studies
confirmed that the majority of regenerated cardiomyocytes
were derived from pre-existing cardiomyocytes through cell
proliferation, similar to earlier studies in zebrafish, as well as
following apical resection in neonatal mice (Haubner et al.,
2012; Porrello et al., 2013). In addition, a robust angiogenic
response was associated with heart regeneration in neonatal
mice (Porrello et al., 2013). Corrosion casting of the coronary
vasculature revealed large collateral vessels in the newly
regenerated anterior wall of the left ventricle that had
originated from the right side of the heart. Consistent with
earlier studies using the apical resection model, 7- and
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Figure 2 Molecular and cellular mechanisms of cardiac regen-
eration in adult zebrafish. Retinoic acid (RA) is produced and
released by epicardial and endocardial cells shortly after injury and
acts on cardiomyocytes to induce proliferation. Other proliferative
cues are also received from non-myocyte populations such as
fibroblasts, which generate several important pro-regenerative
extracellular matrix components such as transforming growth
factor β (TGFβ), tenascin-C and fibronectin. Platelet-derived
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respectively, and act on their cognate receptors (PDGFR and
FGFR) in the epicardium to promote angiogenesis.
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following myocardial infarction, suggesting that cardiac
regenerative capacity was lost within the first two weeks
after birth in rodents (Porrello et al., 2013). These observa-
tions in 7-day-old mice were strikingly concordant with earlier
studies by Robledo in the 1950s, which noted an incomplete
cardiac regenerative response in 4–7 day-old rats following
myocardial burn injury using a heated wire (Robledo, 1956).
Collectively, these findings suggest that the neonatal heart
has a robust capacity for cardiac regeneration following
multiple forms of tissue damage, including myocardial
infarction, but this regenerative potential is rapidly silenced
after birth.
Adding to the growing repertoire of available cardiac injury
models for neonatal mice, Jesty et al. recently reported on
the cardiomyogenic potential of neonatal mice following
cryoinjury (Jesty et al., 2012). In response to cryoinfarction
at 1–3 days-of-age, neonatal mice underwent a marked
cardiomyogenic response and regenerated a large proportion
of the infarcted tissue over a period of 94 days. Consistent
with observations in the apical resection and myocardial
infarction models, neonatal cryoinjury was associated with
robust induction of cardiomyocyte proliferation throughout
the heart (Fig. 1). However, in addition to cardiomyocyte
proliferation, a contribution of c-kit+ cardiac progenitor cells
to cardiomyogenesis and angiogenesis in the neonate was also
noted, suggesting that a pool of cardiac progenitor cells may
be capable of supporting cardiac regeneration in neonatal
mice (Jesty et al., 2012). Although significant scar regression
was observed in this model, it should be noted that re-
generation was not complete at 94 days following cryoinjury.
In contrast, a very recent paper by Strungs et al. has reported
complete regeneration of the neonatal heart following
cryoinjury at P1 and this regenerative potential is lost by P7,
similar to previous findings in apical resection and myocardial
infarction models (Strungs et al., 2013). However, given that
neither Jesty et al. nor Strungs et al. reported the size or
reproducibility of neonatal cryoinfarcts, it is unclear whether
the lack of complete regeneration in the Jesty et al. study is
due to a larger infarct size or the degree of transmurality of
the infarcts. Given that cryoablation of only 25% of the
zebrafish heart is also associatedwith amuchmore protracted
regenerative response (Gonzalez-Rosa et al., 2011), it will be
important to assess the regenerative capacity of the neonatal
mouse heart following small, large, superficial and transmural
infarcts in the future in order to determine the physiological
limits of neonatal heart regeneration.
Although studies in rodents offer a powerful experimental
approach to the developmental regulation of cardiac
regeneration, it is well known that both the timing of
cardiac maturation and the cardiovascular physiology of the
rodent heart are different to large animals, such as humans
(Botting et al., 2012). Therefore, systematic studies of heart
regeneration at different developmental stages in large
animal models are important. While the literature in this
field is sparse, it has been reported that fetal sheep can
undergo regenerative healing following myocardial infarc-
tion during early gestation (Allukian et al., 2013; Herdrich et
al., 2010). Further studies are required to determine the
precise timing and cellular mechanisms underlying regener-
ative arrest in large animal models, including whether this
capacity extends into the immediate postnatal period.Cardiomyocyte proliferation contributes to
cardiomyocyte replenishment during aging
and following injury
An underlying feature of cardiac regeneration in lower
vertebrates and neonatal mice is the robust cardiomyocyte
proliferative response (Oberpriller and Oberpriller, 1971; Poss
et al., 2002; Porrello et al., 2011a; Porrello et al., 2013),
which is absent in non-regenerative adult mammals. In
contrast to zebrafish and newt cardiomyocytes, which remain
predominantly mononucleated and retain proliferative poten-
tial throughout life, most mammalian cardiomyocytes perma-
nently withdraw from the cell cycle before adulthood (Kikuchi
and Poss, 2012). In rodents, cardiomyocytes undergo a final
round of DNA synthesis and karyokinesis in the absence of
cytokinesis, which results in the binucleation of the vast
majority (90–95%) of cardiomyocytes by postnatal day 14 (Li
et al., 1996; Soonpaa et al., 1996; Walsh et al., 2010). In
contrast, binucleation in large mammals, such as sheep, is
typically completed before birth (Jonker et al., 2007).
Interestingly, the proportion of binucleated cardiomyocytes
is much lower in humans than other mammals (~30–40%)
(Mollova et al., 2013). Although the proportion of binucleated
cardiomyocytes does not change after birth in humans, there
is a significant increase in the number of polyploid
cardiomyocytes from birth (~5%) to 40 years of age (~60%)
(Mollova et al., 2013). Indeed, a recent study by Mollova et al.
indicates that cardiomyocytes continue to proliferate, albeit
at a low rate, during the first 20 years of human life (Mollova
et al., 2013), suggesting that the “proliferative window” for
561A neonatal blueprint for cardiac regenerationhuman cardiomyocytes might extend well into childhood and
adolescence.
Over the last decade, a number of studies have proposed
that the adult mammalian heart is not a terminally differen-
tiated organ and is capable of turning over cardiomyocytes
throughout life and following injury (Porrello and Olson,
2010). The most compelling evidence for this radical concept
comes from radiocarbon dating experiments of nuclear DNA
from heart samples that were exposed to nuclear fallout
during weapons testing during the Cold War. These studies
revealed that human cardiomyocytes turn over at a low rate of
about 1% per year, which declines to 0.5% per year after the
age of 50 (Bergmann et al., 2009). The cellular source of these
regenerated cardiomyocytes in humans remains controversial,
but a recent study in mice suggests that cardimoyocyte
proliferation is most likely the dominant cellular mechanism
(Senyo et al., 2013). Therefore, cardiomyocyte proliferation
appears to be the primary natural mechanism for cardiomyo-
cyte replenishment in highly regenerative organisms such as
zebrafish and neonatal mice, as well as in less regenerative
adult mammals. As such, understanding the mechanisms that
govern cardiomyocyte proliferation during development and
regeneration is paramount.Cardiomyocyte proliferative signaling during
neonatal heart development and regeneration
As with many regenerative processes, cardiac regeneration in
adult zebrafish involves the re-engagement of a number of
growth factor signaling pathways that guide embryonic heart
development, including the Igf, RA, Fgf and Notch signaling
pathways (Fig. 2) (Huang et al., 2013; Kikuchi et al., 2011a;
Lepilina et al., 2006; Zhao et al., 2014). However, in contrast
to the capacity of these growth factors to stimulate myocardial
proliferation during embryogenesis and early neonatal life in
mammals, adult mammalian cardiomyocytes do not readily
re-enter the cell cycle in response to similar developmental
cues (Shioi et al., 2000; Collesi et al., 2008). Even in response
to mitogens that are associated with some degree of adult
cardiomyocyte proliferation, such as neuregulin, periostin, FGF
in combination with a p38α MAPK inhibitor or inhibition of
glycogen synthase kinase 3β, only a very low percentage of
adult cardiomyocytes re-enter the cell cycle and complete
cytokinesis, and this effect is thought to be restricted to the
mononucleated subset of cardiomyocytes in rodents (Bersell et
al., 2009; Engel et al., 2006; Engel et al., 2005; Kuhn et al.,
2007; Tseng et al., 2006). Interestingly, even in the highly
proliferative adult newt heart, only ~30% of binucleated
cardiomyocytes were able to undergo cytokinesis, suggesting
that binucleation is a major barrier to cardiomyocyte mitotic
progression (Matz et al., 1998). As such, recent attention has
focused on unraveling the underlying molecular events that
silence the genetic networks required for cardiomyocyte
proliferation during neonatal life.Chromatin remodeling maintains the post-mitotic
cardiac phenotype
Genes are packed in chromatin, which is remodeled into
active (euchromatin) and inactive (heterochromatin) statesby covalent modifications of DNA and histones. The three
primary mechanisms for chromatin-dependent regulation of
gene expression are: DNA methylation, ATP-dependent
chromatin remodeling, and covalent histone modifications,
such as acetylation and methylation. A recent study has
demonstrated that heterochromatin (associated with gene
silencing) accumulates during postnatal cardiomyocyte
maturation and that this is associated with enrichment of
the gene-silencing epigenetic mark H3K9me3 at the pro-
moters of cell cycle genes (Sdek et al., 2011). Interestingly,
both in vivo and in vitro loss-of-function studies indicated that
the recruitment of heterochromatin protein 1-gamma (HP1-γ)
to cell cycle gene promoters resulted in their incorporation
into heterochromatin and irreversible silencing in adult
cardiomyocytes in an Rb/p130-dependent manner (Sdek et
al., 2011). Although the significance of these findings for
cardiac regeneration following ischemic injury is currently
unclear, these results indicate that alterations in chromatin
structure are associated with the maintenance of the
post-mitotic cardiomyocyte phenotype in mammals.
Evidence for a role of epigenetic modifiers in the
regulation of cardiomyocyte proliferation also comes from
a number of genetic gain- and loss-of-function studies in the
mouse. Deletion of the histone deacteylases, Hdac1 and
Hdac2, in cardiomyocytes results in neonatal lethality within
2 weeks after birth due to cardiac arrhythmias and dilated
cardiomyopathy (Montgomery et al., 2007). Combined loss
of Hdac2 and Hopx is also associated with increased
cardiomyocyte proliferation and myocardial thickening and
this effect is mediated through deacetylation of Gata4,
which is a transcription factor that is required for cardio-
myocyte expansion during embryogenesis (Trivedi et al.,
2010). Hdac3 is also involved in the regulation of cardio-
myocyte proliferative capacity, as over-expression of Hdac3
in cardiomyocytes stimulates proliferation by suppressing
the expression of a number of cyclin-dependent kinase
inhibitors (Trivedi et al., 2008). In addition, histone
methyltransferases and demethylases have been implicated
in the regulation of cardiomyocyte mitosis during embryo-
genesis, with Jumonji and Smyd1 mutants both displaying
severe ventricular hypoplasia phenotypes (Toyoda et al., 2003;
Park et al., 2010). Similarly, genetic deletion of the ATP-
dependent chromatin-remodeling factor, Brahma-related gene
1 (Brg1), is associated with myocardial proliferative defects
in mice (Hang et al., 2010). Taken together, these findings
support the contention that epigenetic events underlie the
maintenance of the proliferative state and expression of
fetal genes during cardiac development. Future studies will
be required to determine the relative importance of these
epigenetic events for postnatal silencing of cardiac regenera-
tive potential in mammals.Regulation of cardiomyocyte proliferation and cardiac
regeneration by microRNAs
MiRNAs are now recognized as central modulators of cardiac
development and disease. Given their capacity to suppress
large collections of proteins participating in common signaling
pathways, miRNAs could be engaged as important biological
and therapeutic regulators of cardiomyocyte proliferation
(Porrello, 2013). In an attempt to identify miRNAs involved in
562 E.R. Porrello, E.N. Olsonpostnatal cardiomyocyte mitotic arrest, microarrays were
used to profile miRNAs in 1- and 10-day-old mouse hearts
(Porrello et al., 2011b). One of the most highly up-regulated
miRNAs during this developmental window was miR-195, a
member of the miR-15 family, which was previously identified
as a critical tumor suppressor miRNA (Bonci et al., 2008; Klein
et al., 2010). Gain- and loss-of-function studies in the mouse
subsequently validated the miR-15 family as an important
regulator of postnatal cardiomyocyte mitotic arrest. Over-
expression of miR-195 in developing cardiomyocytes was
associated with premature cell cycle arrest and a subset of
transgenic mice displayed congenital abnormalities including
ventricular septal defects (Porrello et al., 2011b). Following
myocardial infarction at P1, miR-195 transgenic mice also
failed to regenerate and formed large fibrotic scars with
an associated decline in cardiac contractile function (Porrello
et al., 2013). In contrast, postnatal inhibition of the entire
miR-15 family using locked nucleic acid (LNA)-modified
antimiRs prolonged the proliferative capacity of neonatal
cardiomyocytes beyond the normal window of postnatal cell
cycle arrest (Porrello et al., 2011b). Furthermore, postnatal
inhibition of the miR-15 family induced cardiomyocyte
proliferation and improved cardiac function in adult mice
subjected to ischemia–reperfusion injury (Porrello et al.,
2013). Importantly, acute inhibition of the miR-15 family in
small and large animal models is also associated with an
improvement in cardiac function following ischemia–reperfu-
sion injury (Hullinger et al., 2012), but whether this effect is
due in part to cardiomyocyte cell cycle re-entry is currently
unclear. Consistent with the effects of the miR-15 family
on cardiomyocyte proliferation, a number of cell cycle
genes, including checkpoint kinase 1 (Chek1), have been
identified as important downstream target genes (Porrello
et al., 2011b). Taken together, these results suggest that
the miR-15 family is an important regulator of cardiomyo-
cyte mitosis and cardiac regenerative capacity during the
neonatal period.
Another group of miRNAs that is critical for postnatal
cardiomyocyte mitotic arrest is the miR-17~92 cluster. The
miR-17–92 cluster was originally identified as a human
oncogene and genetic loss-of-function studies in mice had
previously revealed important functions for this miRNA cluster
during embryonic heart development (Ventura et al., 2008;
Wang et al., 2010). A recent study has also assessed the
effects of miR-17–92 gain- and loss-of-function on cardio-
myocyte proliferation during embryogenesis and postnatal
life. Cardiomyocyte-specific deletion of themiR-17–92 cluster
demonstrated an essential role during cardiomyocyte prolif-
eration in embryonic and postnatal hearts (Chen et al., 2013).
Moreover, transgenic over-expression of miR-17–92 was
sufficient to induce cardiomyocyte proliferation in adult
hearts and was associated with enhanced cardiac function
following myocardial infarction (Chen et al., 2013). miR-17–
92 appears to exert its biological actions through regulation of
the phosphatase and tensin homolog (PTEN), an important
regulator of phosphoinositide 3-kinase (PI3K) signaling. Al-
though further studies are required to determine whether
miR-17–92 plays any role during endogenous regeneration of
the neonatal heart, these findings suggest that activation of
this miRNA cluster may represent a potentially important
strategy towards induction of cardiomyocyte proliferation and
cardiac regeneration in adults.A recent study by Eulalio et al. has identified dozens of
additional miRNAs with previously unknown roles in cardiomyo-
cyte proliferation (Eulalio et al., 2012). In this study,
cardiomyocytes were systematically screened against a library
of 875miRNAmimics to identify potential candidates capable of
inducing cardiomyocyte proliferation. As two of themost potent
inducers of cardiomyocyte proliferation, miR-199a and miR-590
were selected for further follow-up studies. In a powerful
demonstration of the utility of functional genomic screens,
over-expression of miR-199a and miR-590 respectively, was
sufficient for induction of cardiomyocyte proliferation in vivo in
neonatal and adult mice. Moreover, over-expression of these
miRNAs was associated with increased cardiomyocyte prolifer-
ation rates, cardiac regeneration, reduced fibrotic scarring and
improved cardiac function following myocardial infarction
(Eulalio et al., 2012). A number of putative downstream target
genes were identified for miR-199a and miR-590, including the
Ca2+ signaling regulator Homer1, the homeodomain protein
Hopx, and the chloride intracellular channel 5 (Clic5), all of
which were demonstrated to inhibit cardiomyocyte prolifera-
tion (Eulalio et al., 2012). These findings further highlight the
critical role of miRNAs during cardiomyocyte maturation and
suggest that miRNAs may prove to be important drug targets for
cardiac regeneration in the future.Induction of cardiac regeneration through inhibition
of Hippo signaling
The Hippo signaling pathway has emerged as a major
regulator of organ size in diverse species. The core signaling
components of the Hippo pathway in mammals include the
mammalian STE20-like protein kinases 1 and 2 (Mst1 and
Mst2), the scaffolding protein Salvador (SAV), the large
tumor suppressor homolog 1 and 2 (LATS1 and LATS2) protein
kinases, Yes-associated protein (YAP) and the transcriptional
co-activator with PDZ-binding motif (TAZ). Following activa-
tion of this signaling cascade, the transcriptional co-activators
Yap and Taz become phosphorylated, which results in their
exclusion from the nucleus and disrupts their association
with DNA binding transcription factors that normally drive
cellular growth. In the heart, genetic deletion of Salvador
during embryonic development in the mouse is associated
with massively overgrown hearts and elevated cardiomyocyte
proliferation indices (Heallen et al., 2011). Ablation of Mst1/2
or Lats2 causes a similar embryonic cardiac phenotype (Heallen
et al., 2011). Interestingly, Salvador deletion was associat-
ed with the up-regulation of a number of Wnt target genes
and an increase in nuclear β-catenin, suggesting that
there is considerable cross-talk between the Hippo and
canonical Wnt/β-catenin signaling pathways. Indeed, reduc-
ing the levels of β-catenin rescues the cardiomyocyte pro-
liferation phenotype in Salvador knockout mice (Heallen et
al., 2011).
Recent studies have also established that the transcrip-
tional co-activator Yap is both necessary and sufficient to
drive cardiomyocyte proliferation during embryogenesis and
neonatal heart regeneration. Genetic loss-of-function studies
have revealed that Yap is required for cardiomyocyte
proliferation during embryonic heart development (von Gise
et al., 2012; Xin et al., 2013; Xin et al., 2011). Deletion of Yap
in the embryonic mouse heart causes myocardial hypoplasia
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2011). Similarly, deletion of Yap in the postnatal heart results
in a progressive dilated cardiomyopathy and is associated with
a reduced number of mitotic cardiomyocytes during the
neonatal period (Xin et al., 2013). Following neonatal
myocardial infarction, Yap cardiac-knockout mice fail to
mount a regenerative response and instead are characterized
by cardiac fibrosis and cardiac dilation, reminiscent of
pathological cardiac remodeling in adult mice (Xin et al.,
2013). Conversely, over-expression of a constitutively active
form of Yap in the embryonic heart increases cardiomyocyte
number and heart size (Xin et al., 2011). Over-expression of
constitutively active Yap in cultured neonatal cardiomyocytes
in vitro was also associated with induction of cardiomyocyte
proliferation and this effect operates through activation of the
IGF signaling pathway and downstream inactivation of GSK3β.
Moreover, transgenic over-expression of constitutively active
Yap in postnatal cardiomyocytes is sufficient to drive
cardiomyocyte proliferation, reduce fibrosis and improve
cardiac function following myocardial infarction in adult
mice (Xin et al., 2013). Similar results were also reported in
cardiomyocyte-specific Salvador knockout mice, which dem-
onstrated an enhanced regenerative response and diminished
fibrotic response to either apical resection injury or myocar-
dial infarction at post-natal day 8 (Heallen et al., 2013). These
findings demonstrate that the Hippo signaling pathway is a
critical regulator of cardiomyocyte proliferation and cardiac
regeneration in mammals.Meis1 defines a transcriptional hierarchy for
cardiomyocyte proliferation
In contrast to the transcriptional networks that govern early
embryonic heart development, little is known about the
transcriptional regulation of postnatal cardiomyocyte matu-
ration. To this end, a recent study by Mahmoud et al.M
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Figure 3 Molecular and cellular mechanisms of cardiac regen
angiogenesis are both required for complete regeneration of the neo
neonatal heart is activated by Yap and restricted by the miR-15 fam
where they promote angiogenesis.identified a novel role for the transcription factor Meis1
during postnatal cardiomyocyte cell cycle arrest (Mahmoud et
al., 2013). Meis1 belongs to the TALE (three amino acid loop
extension) family of homeodomain transcription factors and
was previously shown to play an important role during
embryonic hematopoiesis and heart development (Hisa
et al., 2004; Stankunas et al., 2008). Recent genome-wide
epigeneticmapping studies have revealed important functions
for Meis transcription factors during cardiac differentiation
(Paige et al., 2012; Wamstad et al., 2012). These studies have
shown that Meis transcription factors act independently, as
well as in concert with other important cardiac transcription
factors such as Gata4, to regulate a plethora of genes with
important roles in cardiac development (Paige et al., 2012;
Wamstad et al., 2012). However, the functions of Meis
transcription factors in the post-natal heart have only recently
begun to be elucidated. Constitutive deletion of Meis1 in the
postnatal mouse heart was associated with an increased
incidence of cardiomyocyte proliferation (Mahmoud et al.,
2013). Importantly, conditional deletion of Meis1 in the adult
heart was sufficient to induce cardiomyocyte cell cycle
re-entry in a subset of adult cardiomyocytes. PCR arrays and
transcriptional assays subsequently revealed that Meis1 was
required for transcriptional activation of the synergistic
cyclin-dependent kinase (CDK) inhibitors p15, p16 and p21,
thus identifying Meis1 as an important upstream component of
the transcriptional hierarchy that governs cardiomyocyte cell
cycle arrest after birth (Mahmoud et al., 2013).
In order to determine the role of Meis1 during neonatal heart
regeneration, inducible transgenic mice were subjected to
myocardial infarction at P1. In contrast towild-typemice, Meis1
over-expression in the neonatal heart reduced the number of
mitotic cardiomyocytes following injury and was associated
with a much more limited regenerative response characterized
by increased fibrotic scarring and cardiac contractile dysfunc-
tion (Mahmoud et al., 2013). Therefore, similar to miR-195
over-expression or Yap deletion, Meis1 over-expression isφ
on
Meis1
sis
Regeneration
eration in neonatal mice. Cardiomyocyte proliferation and
natal heart following injury. Cardiomyocyte proliferation in the
ily and Meis1. Macrophages are also recruited to the injury site
564 E.R. Porrello, E.N. Olsonsufficient to impair the neonatal cardiac regenerative response
through inhibition of cardiomyocyte proliferation (Fig. 3).
Endogenous cardiac stem and progenitor cells
Resident tissue stem and progenitor cell populations reside in
most adult tissues and contribute to cellular homeostasis and
repair throughout life. In the heart, several cardiac stem/
progenitor populations have been identified at different
developmental stages including the embryonic, neonatal and
adult heart. Cardiac stem cells have been identified on the
basis of cell surface marker expression (e.g. c-kit, Sca-1),
transcription factor expression (e.g. Isl-1), physiological dye
efflux properties and propensity to formmulticellular clusters
(e.g. cardiospheres, colony-forming units-fibroblasts (cfu-f))
(Beltrami et al., 2003; Chong et al., 2011; Oh et al., 2003;
Jackson et al., 2001; Messina et al., 2004; Laugwitz et al.,
2005). Given that mammalian cardiomyocyte renewal is
extremely limited in the adult heart following infarction, it
is important to determine whether cardiac stem cells might
play an important role in more highly regenerative organisms,
such as zebrafish and neonatal mice.
Epicardial progenitors in the regenerating heart
The epicardium is a single mesothelial layer of cells that
envelops the heart. Genetic lineage tracing studies in the
mouse using Cre-loxP technology have identified the epicardi-
um as a reservoir of multipotent cardiac progenitor cells that
provide an important source of fibroblasts, vascular smooth
muscle cells, perivascular cells and cardiomyocytes during
embryogenesis (Cai et al., 2008; Christoffels et al., 2009; Zhou
et al., 2008). Thus, the role of epicardial cells during cardiac
regeneration has also attracted significant interest. However,
lineage-tracing studies have so far failed to identify a major
contribution of the epicardial lineage to cardiomyogenesis
following myocardial infarction in adult mice or following
cardiac injury in adult zebrafish (Kikuchi et al., 2011b; Zhou
et al., 2011).
Epicardial genes are rapidly activated in an organ-wide
manner in adult zebrafish and neonatal mice following cardiac
injury (Porrello et al., 2011a; Lepilina et al., 2006). In
zebrafish, the epicardium provides an important source
of growth factors such as RA and Pdgf, which support
cardiomyocyte proliferation and cardiac regeneration
(Fig. 2) (Kikuchi et al., 2011a; Kim et al., 2010). In addition,
Kikuchi et al. and Gonzales-Rosa et al. traced the descendants
of the tcf21+ epicardial lineage and identified myofibroblasts
and perivascular cells derived from this cell source following
apical resection or cryoinjury, respectively (Kikuchi et al.,
2011b; Gonzalez-Rosa et al., 2012). Neither study identified
any cardiomyocytes derived from the epicardial lineage
during cardiac regeneration. However, the vascular and
cardiomyogenic potential of epicardial cells could potentially
be enhanced in the adult heart following injury by treatment
with specific growth factors. For example, the peptide
thymosin β4 has been shown to enhance the vascular and
cardiomyogenic potential of epicardial progenitor cells in vivo
following myocardial infarction (Smart et al., 2011; Smart
et al., 2007). It will be important in the future to determine
the relative contribution of epicardial progenitors to differentcardiac lineages during neonatal mammalian heart regen-
eration in order to identify any potential developmental
mechanisms that could be exploited to enable cardiac
regeneration in adults.
c-kit progenitor cells and neonatal heart regeneration
To determine whether c-kit+ cells are capable of supporting
regeneration of the neonatal heart, Jesty et al. subjected
neonatal and adult c-kit-EGFP reporter mice to cryoinjury
(Jesty et al., 2012). Cardiac injury in neonatal mice was
associated with robust activation of c-kit around the site of
injury but not in remote regions. Interestingly, a substantial
proportion of c-kit+ cells was of a cardiac phenotype at day 3
(67%) and day 7 (88%) following cryoinfarction (Jesty et al.,
2012). The majority of the remaining c-kit+ cells were
endothelial cells. In vivo pulse-labelingwith BrdU also identified
a substantial proportion of proliferating cardiomyocytes in the
regenerating neonatal heart that were positive for c-kit (42% at
day 5 post-cryoinfarction) (Jesty et al., 2012). In contrast, adult
c-kit+ cells adopted a vascular fate following cryoinfarction and
did not contribute to cardiomyocyte formation, a finding that
contradicts other reports of a robust cardiomyogenic potential
for this stem cell population in adults (Beltrami et al., 2003;
Waring et al., 2012). While this study supports the notion of a
differential regenerative capacity of the neonatal and adult
heart, which may be in part accounted for by physiological
alterations in the properties of c-kit+ cells, some caveats
warrant further investigation. In particular, precise lineage
tracing studies and ablation of the c-kit+ cell population in
neonatal mice, as reported recently for this cell population in
an adult isoproterenol-induced heart failure model (Ellison et
al., 2013), will be required to fully establish the contribution of
this stem cell population to neonatal heart regeneration.
Furthermore, given that c-kit is expressed by differenti-
ated cardiomyocytes (Li et al., 2008), de-differentiating
cardiomyocytes (Kubin et al., 2011; Zhang et al., 2010)
and mast cells (Huang et al., 1990), the relative activity
of this reporter construct in these different cell populations
will need to be ascertained in order to perform controlled
genetic fate mapping studies. It will also be interesting to
determine whether cardiac stem cells exert paracrine effects
that support heart regeneration during early developmental
stages in mammals.
Angiogenic and vasculogenic responses during
heart regeneration
Re-establishment of a new vasculature following cardiac
injury is vital for heart regeneration. In neonatal mice, large
epicardial blood vessels are evident in the regenerated heart
following apical resection injury (Porrello et al., 2011a).
Recent studies also indicate that cardiac regeneration
following neonatal myocardial infarction is associated with
a robust vasculogenic response with large collateral vessels
penetrating the infarcted territory during regeneration
(Porrello et al., 2013). In contrast, a similar vascular injury
response is not evident in adult rodents, suggesting that
important developmental differences in the reparative
potential of vascular cells may contribute to the loss of
cardiac regenerative capacity during the neonatal period.
565A neonatal blueprint for cardiac regenerationTwo of the most important pro-angiogenic factors during
zebrafish heart regeneration are Fgf and Pdgf (Fig. 2).
Following apical resection injury, Fgf ligands, such as
fgf17b, are up-regulated in the myocardium, while the Fgf
receptors fgfr2 and fgfr4 are induced in epicardial cells
(Lepilina et al., 2006). Transgenic loss-of-function studies in
the zebrafish have established that Fgf receptor expression
in epicardial cells is required for epicardial cell invasion into
the wound site and neovascularization. In the absence of Fgf
receptor-dependent neovascularization, the zebrafish heart
fails to regenerate following injury and forms a large fibrotic
scar (Lepilina et al., 2006). Similarly, Pdgf signaling is also
required for epicardial cell proliferation and blood vessel
formation following cardiac injury in zebrafish. The PDGF
receptor alpha (pdgfrα) gene is up-regulated in epicardial
cells and at the wound site following apical resection injury,
while the PDGF-B ligand is expressed locally in the wound
site by CD41-positive thrombocytes (Kim et al., 2010; Lien et
al., 2006). Pharmacological inhibition of Pdgf signaling
inhibits neovascularization following apical resection injury
(Kim et al., 2010). These findings have established an
important myo-epicardial growth factor signaling nexus
during cardiac regeneration and it will be important to
establish whether these signaling pathways are also activat-
ed during neonatal heart regeneration in mammals. Given
the exciting recent developments in modified RNA-based
delivery methods for angiogenic growth factors, such as
vascular endothelial growth factor (VEGF) (Zangi et al.,
2013), it may be possible to recapitulate some of these
pro-regenerative and pro-angiogenic signaling pathways in
the adult heart in the future.
The extracellular matrix facilitates cardiac
regeneration
The predominant reparative response to cardiac injury in
adult mammals involves the replacement of damaged myo-
cardial tissue with a permanent collagenous scar. Cardiac
fibroblasts account for up to two thirds of all cardiac cells and
are embedded within the extracellular matrix (ECM) where
they secrete the collagens required for matrix synthesis, as
well as growth factors that support cardiomyocyte function
and remodeling (Porter and Turner, 2009). In contrast to the
fibrotic response of the adult heart following infarction, the
neonatal heart does not form a stable fibrotic scar. However,
there is considerable ECM deposition during the first week
following cardiac injury in neonatal mice (Porrello et al.,
2011a; Porrello et al., 2013). Subsequently, the fibrotic tissue
becomes marginalized to the periphery and regresses over
several weeks before being almost completely replaced with
regenerated cardiomyocytes (Porrello et al., 2013). In the
absence of an adequate myocyte proliferative response in the
neonate, the default repair response is characterized by the
presence of a fibrotic scar (Porrello et al., 2013; Xin et al.,
2013; Mahmoud et al., 2013). These findings suggest that
there is a reciprocal relationship between cardiomyocyte
proliferation and fibrosis. Although little is known about the
communication between fibroblasts and cardiomyocytes at
early developmental stages, there is some evidence that
cardiac fibroblasts regulate myocardial proliferation during
embryogenesis. For example, fibronectin, collagen andheparin-binding EGF-like growth factor are all produced by
embryonic cardiac fibroblasts and can promote proliferation
of immature cardiomyocytes (Ieda et al., 2009). These
proliferative effects are dependent on the expression of
the ECM receptor, β1 integrin, in cardiomycytes. Interesting-
ly, the expression of different integrin subunits (e.g. Itga1,
Itgb1, Itga6 and Itga7), which have varying propensities to
bind to different ECM components (e.g. collagen, laminin,
fibronectin), changes during cardiomyocyte maturation (Ieda
et al., 2009). It is therefore possible that postnatal changes in
the ECM contribute to cardiomyocyte cell cycle withdrawal
during the neonatal period. Furthermore, as re-establishment
of the ECM is important for heart regeneration, further
studies will be required in order to determine whether ECM
components provide integral signals for neonatal heart
regeneration.
Results from several recent studies in lower vertebrates are
consistent with an important role for ECM-derived signals for
heart regeneration (Fig. 2). Fibronectin, a major component
of the ECM, is secreted by epicardial cells and deposited at the
injury site after cardiac injury in zebrafish (Wang et al., 2013).
Loss-of-function experiments established that fibronectin is
required for cardiac regeneration in zebrafish, although it
does not affect cardiomyocyte proliferation in this species
(Wang et al., 2013). The mechanism by which ECM-derived
fibronectin influences heart regeneration in zebrafish is
currently unknown but could be due to a potential role of
fibronectin signaling on cardiomyocyte migration or epicardial
cell function. On the other hand, transforming growth factor
beta (TGFβ) ligands and receptors (tgfbr1b) are induced
in fibroblasts and cardiomyocytes following cryoinjury in
zebrafish and are required for cardiac regeneration (Chablais
and Jazwinska, 2012). Transient scar formation was found
to be an essential step in the zebrafish regenerative response
following cryoinjury and pharmacological inhibition of TGFβ
signaling abolished the regenerative response (Chablais
and Jazwinska, 2012). Thus, early ECM deposition and TGFβ-
mediated cardiomyocyte proliferative signals are required for
zebrafish heart regeneration. Furthermore, a recent study in
adult newts has established that early up-regulation of ECM
components in the epicardium precedes cardiomyocyte pro-
liferation and migration in this species. Interestingly, the
ECM-derived component tenascin-Cwas shown to be sufficient
to induce cardiomyocyte proliferation in vitro, suggesting
that ECM-derived signals in the adult newt are also required
for induction of cardiomyocyte proliferation during cardiac
regeneration (Mercer et al., 2013).
Do neonatal immune responses dictate cardiac
regenerative outcomes?
Cardiac injury in lower vertebrates, neonatal mice and adult
mammals is associated with inflammation, yet the physiolog-
ical consequences of injury in neonatal and adultmammals are
vastly different. The immune response is important for
clearing cellular debris following myocardial infarction in
adults but it also facilitates scar formation, which ultimately
compromises cardiac function (Frangogiannis, 2012). Indeed,
multiple lines of evidence support the notion that the adult
mammalian immune system constrains regenerative capacity
and recent studies suggest that the immune response to injury
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Godwin et al., 2013; Kyritsis et al., 2012). In mammals, the
adaptive and innate immune systems undergo drastic alter-
ations and maturation during the neonatal period, coinciding
with the developmental loss of cardiac regenerative capacity
(Adkins et al., 2004; Kincade et al., 2002; Lu et al., 2002;
Garcia et al., 2000).
A recent study by Aurora et al. suggests that these
postnatal changes in the immune system may also play an
important role in dictating regeneration versus repair
responses of the neonatal heart following injury (Aurora et
al., 2014). Through systematic profiling of the cellular
immune response to cardiac injury, Aurora et al. identified a
number of qualitative and quantitative differences in the
cellular immune response of 1-day-old (regenerative) and
14-day-old (non-regenerative) mice following myocardial
infarction. Differences in the monocyte and macrophage
responses to cardiac injury in neonatal mice were particularly
prevalent. Subsequent depletion of macrophages in neonatal
mice using a clodronate-liposome depletion method revealed
that macrophages are required for neonatal heart regenera-
tion following myocardial infarction. In contrast to the
pro-fibrotic role of macrophages in the adult heart, neonatal
macrophages were found to be required for heart regenera-
tion. Interestingly, macrophages did not influence cardiomyo-
cyte proliferation following infarction but were essential for
angiogenesis (Fig. 3). Molecular profiling of macrophages in
the regenerating (P1) and non-regenerating (P14) heart
following infarction revealed a unique transcriptional signa-
ture of neonatal macrophages, including the expression of
several potentially important pro-angiogenic cytokines. Fu-
ture studies will be required to uncover the underlying
mechanisms that govern these developmentally distinct
macrophage responses to injury. In addition, whether the
absence of regeneration in adult mammals is due to
differences in the types of inflammatory cells that are
recruited, the specific signals secreted from inflammatory
cells, or the responsiveness of different cardiac cell types to
these inflammatory stimuli remains to be determined.Conclusions and future perspectives
It has been suggested that developmental mechanisms are
prisoners of their own phylogenetic histories (Goss, 1991).
On the basis of recent studies of cardiac regeneration in
fetal/neonatal mammals, it would appear that regenera-
tive mechanisms are also prisoners of their developmental
histories. These findings raise the following question —
what is the evolutionary advantage of shutting down
cardiac regenerative pathways after birth? It appears that
in the absence of any selective pressure to maintain
regenerative capacity in organisms that typically don't
succumb to cardiovascular disease until well after
reproductive maturity, there may not have been a strong
evolutionary drive to maintain regenerative potential
after birth in mammals. So, what could be the advantage
of arresting cardiomyocyte proliferation after birth? In
mammals, the heart undergoes a number of physiological
adaptations during the immediate postnatal period to
cope with the increased loading and oxygen demands
associated with the pulmonary circulation, and the rapidgrowth demands of postnatal life (Gao and Raj, 2010).
These environmental and physiological stressors are
matched by marked structural and metabolic adaptations
in the cardiomyocyte, including a switch from glycolyis to
fatty acid oxidation and sarcomere reorganization, both
of which are suited to the high-energy demands of the
postnatal heart (Pohjoismaki et al., 2012). Given the
requirement to disassemble sarcomeres during cell divi-
sion (Ahuja et al., 2004), cardiomyocyte proliferation may
not be particularly advantageous during postnatal life in
mammals and this adaptation may have come at the
expense of cardiac regeneration. An important aspect of
future studies that attempt to recapitulate early devel-
opmental regenerative mechanisms, including cardiomyo-
cyte cell cycle re-entry, will be to establish whether
these approaches have any detrimental effects on adult
cardiac physiology. It is our belief that understanding the
detailed physiological and molecular mechanisms that
drive cardiomyocyte maturation and regenerative arrest
during neonatal life will be imperative for establishing
the biological basis and clinical utility of future cardiac
regenerative therapies.
Much work remains to be done in order to identify the
molecular and cellular basis for neonatal heart regener-
ation. However, recent studies suggest that re-activation
of neonatal cardiac regenerative pathways to drive
cardiomyocyte proliferation in the adult heart may be
possible (Porrello et al., 2013; Xin et al., 2013; Mahmoud
et al., 2013). Given the ever-expanding molecular
genetic and pharmacological toolkit for studies in mam-
mals and lower vertebrates, it is likely that many more
natural cardiac regenerative mechanisms will be identi-
fied in the near future. If successful, these studies may
indeed uncover a developmental blueprint for cardiac
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